Conquering Diseases

A Study Comparing Two Ways To Address Spontaneously Breathing In Newborns With Respiratory Distress Syndrome (Rds)

Description

Seeking male and female preterm newborns who have been diagnosed with Respiratory Distress Syndrome.

Overview

The respiratory disorder caused by lack of a naturally produced substance called surfactant in the immature lung of preterm babies is called “Respiratory Distress Syndrome” (RDS). The purpose of this study is to assess how safe and effective it is to use a different method of administration of the medication used to address RDS compared to the standard method.

What we're hoping for

Evaluate the safety and effectiveness of an investigational thin catheter to administer Curosurf for preterm babies who have signs of of RDS, compared with the standard method of administration (ET Tube).

Additional Information

ClinicalTrials.gov Identifier: NCT02772081

 Principal Investigator

Lawrence  Rhein, MD, MPH

UMass Memorial Health Care

 Study Contact

Lindsey  Simoncini

508-334-8774

lindsey.simoncini@umassmed.edu

 Location

UMMHC Memorial Campus

281 Lincoln St. 

Worcester,MA 01605

508-334-1000